{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:51:07Z","timestamp":1774842667477,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2016.80","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T15:27:10Z","timestamp":1474644430000},"page":"e475-e475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"6","author":[{"given":"J","family":"Vargova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Vargova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Dusilkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Kulvait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Pospisil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Zavadil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Trneny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Klener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"key":"BFbcj201680_CR1","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","volume":"106","author":"K Fu","year":"2005","unstructured":"Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005; 106: 4315\u20134321.","journal-title":"Blood"},{"key":"BFbcj201680_CR2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3109\/10428194.2014.953147","volume":"56","author":"AM Wasik","year":"2015","unstructured":"Wasik AM, Priebe V, Lord M, Jeppsson-Ahlberg A, Christensson B, Sander B . Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia\/small lymphocytic lymphoma from mantle cell lymphoma. Leuk Lymphoma 2015; 56: 1425\u20131431.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj201680_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2141.1995.tb05167.x","volume":"90","author":"A Cuneo","year":"1995","unstructured":"Cuneo A, Balboni M, Piva N, Rigolin GM, Roberti MG, Mejak C et al. Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation. Br J Haematol 1995; 90: 409\u2013416.","journal-title":"Br J Haematol"},{"key":"BFbcj201680_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1309\/AJCPT32JDFIGHFHJ","volume":"143","author":"C Amador-Ortiz","year":"2015","unstructured":"Amador-Ortiz C, Goolsby CL, Peterson LC, Wolniak KL, McLaughlin JL, Gao J et al. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia\/small lymphocytic lymphoma. Am J Clin Pathol 2015; 143: 214\u2013222.","journal-title":"Am J Clin Pathol"},{"key":"BFbcj201680_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12185-015-1847-4","volume":"102","author":"H Huskova","year":"2015","unstructured":"Huskova H, Korecka K, Karban J, Vargova J, Vargova K, Dusilkova N et al. Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas. Int J Hematol 2015; 102: 441\u2013450.","journal-title":"Int J Hematol"},{"key":"BFbcj201680_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.leu.2404520","volume":"21","author":"NC Gutierrez","year":"2007","unstructured":"Gutierrez NC, Ocio EM, de Las Rivas J, Maiso P, Delgado M, Ferminan E et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals. Leukemia 2007; 21: 541\u2013549.","journal-title":"Leukemia"},{"key":"BFbcj201680_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1074\/mcp.M600077-MCP200","volume":"5","author":"S Ek","year":"2006","unstructured":"Ek S, Andreasson U, Hober S, Kampf C, Ponten F, Uhlen M et al. From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol Cell Proteomics 2006; 5: 1072\u20131081.","journal-title":"Mol Cell Proteomics"},{"key":"BFbcj201680_CR8","doi-asserted-by":"publisher","first-page":"e0128990","DOI":"10.1371\/journal.pone.0128990","volume":"10","author":"E Cornet","year":"2015","unstructured":"Cornet E, Debliquis A, Rimelen V, Civic N, Docquier M, Troussard X et al. Developing molecular signatures for chronic lymphocytic leukemia. PLoS One 2015; 10: e0128990.","journal-title":"PLoS One"},{"key":"BFbcj201680_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/356618a0","volume":"356","author":"JH Hartwig","year":"1992","unstructured":"Hartwig JH, Thelen M, Rosen A, Janmey PA, Nairn AC, Aderem A . MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 1992; 356: 618\u2013622.","journal-title":"Nature"},{"key":"BFbcj201680_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1139\/o03-087","volume":"82","author":"M Sundaram","year":"2004","unstructured":"Sundaram M, Cook HW, Byers DM . The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components. Biochem Cell Biol 2004; 82: 191\u2013200.","journal-title":"Biochem Cell Biol"},{"key":"BFbcj201680_CR11","doi-asserted-by":"publisher","first-page":"e0140870","DOI":"10.1371\/journal.pone.0140870","volume":"10","author":"TD Rohrbach","year":"2015","unstructured":"Rohrbach TD, Shah N, Jackson WP, Feeney EV, Scanlon S, Gish R et al. The effector domain of MARCKS is a nuclear localization signal that regulates cellular PIP2 levels and nuclear PIP2 localization. PLoS One 2015; 10: e0140870.","journal-title":"PLoS One"},{"key":"BFbcj201680_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0014-5793(92)80557-W","volume":"297","author":"B Amess","year":"1992","unstructured":"Amess B, Manjarrez-Hernandez HA, Howell SA, Learmonth M, Aitken A . Multisite phosphorylation of the 80 kDa (MARCKS) protein kinase C substrate in C3H\/10T1\/2 fibroblasts. Quantitative analysis of individual sites by solid-phase microsequencing. FEBS Lett 1992; 297: 285\u2013291.","journal-title":"FEBS Lett"},{"key":"BFbcj201680_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/leu.2014.255","volume":"29","author":"Y Yang","year":"2015","unstructured":"Yang Y, Chen Y, Saha MN, Chen J, Evans K, Qiu L et al. Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma. Leukemia 2015; 29: 715\u2013726.","journal-title":"Leukemia"},{"key":"BFbcj201680_CR14","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1038\/onc.2013.336","volume":"33","author":"CH Chen","year":"2014","unstructured":"Chen CH, Thai P, Yoneda K, Adler KB, Yang PC, Wu R . A peptide that inhibits function of myristoylated alanine-rich C kinase substrate (MARCKS) reduces lung cancer metastasis. Oncogene 2014; 33: 3696\u20133706.","journal-title":"Oncogene"},{"key":"BFbcj201680_CR15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrd3871","volume":"11","author":"D Mochly-Rosen","year":"2012","unstructured":"Mochly-Rosen D, Das K, Grimes KV . Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov 2012; 11: 937\u2013957.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201680","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:51:11Z","timestamp":1672822271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":15,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"alternative-id":["BFbcj201680"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2016.80","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]},"assertion":[{"value":"23 September 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}